Insomnia disorder: clinical and research challenges for the 21st century.

Ferini-Strambi, Luigi; Auer, Reto; Bjorvatn, Bjørn; Castronovo, Vincenza; Franco, Oscar; Gabutti, Luca; Galbiati, Andrea; Hajak, Goeran; Khatami, Ramin; Kitajima, Tsuyoshi; McEvoy, Doug; Nissen, Christoph; Perlis, Michael; Pevernagie, Dirk A; Randerath, Winfried; Riemann, Dieter; Rizzo, Giovanni; Van Someren, Eus; Vgontzas, Alexandros; Barazzoni, Fabrizio; ... (2021). Insomnia disorder: clinical and research challenges for the 21st century. European journal of neurology, 28(7), pp. 2156-2167. Blackwell Science 10.1111/ene.14784

[img] Text
FeriniStrambi_EurJNeurol_2021_AAM.pdf - Accepted Version
Restricted to registered users only until 23 February 2022.
Available under License Publisher holds Copyright.

Download (11MB) | Request a copy

BACKGROUND

Insomnia is a common and debilitating disorder that is frequently associated with important consequences for physical health and well-being.

METHODS

An international expert group considered the current state of knowledge based on the most relevant publications in the previous 5 years, discussed the current challenges in the field of insomnia, and identified future priorities.

RESULTS

The association of trajectories of insomnia with subsequent quality of life, health, and mortality should be investigated in large populations. Prospective health economic studies by separating the specific costs driven specifically by insomnia and costs attributable to its long-term effects are needed. Ignoring the heterogeneity of insomnia patients leads to inadequate diagnosis and inefficient treatment. Individualized interventions should be promoted. More data are needed on both the impact of sleep on overnight effects, such as emotion regulation, and the potential compensatory effort to counteract diurnal impairments. Another gap is the definition of neurocognitive deficits in insomnia patients compared to normal subjects after chronic sleep loss. There are also a number of key gaps related to insomnia treatment. Expert guidelines indicate cognitive-behavioral therapy for insomnia (CBT-I) as first line treatment. They neglect, however, the reality of major health care providers. The role of combined therapy, CBT-I plus pharmacological treatment, should more extensively evaluated.

CONCLUSION

While insomnia disorder might affect large proportions of the population, there are a number of significant gaps in the epidemiological/clinical/research studies carried out to date. In particular, the identification of different insomnia phenotypes could allow more cost-effective and efficient therapies.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Translational Research Center
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)
04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)

UniBE Contributor:

Auer, Reto; Franco Duran, Oscar Horacio; Nissen, Christoph and Bassetti, Claudio

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1351-5101

Publisher:

Blackwell Science

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

15 Mar 2021 12:00

Last Modified:

12 Jun 2021 01:32

Publisher DOI:

10.1111/ene.14784

PubMed ID:

33619858

BORIS DOI:

10.48350/152800

URI:

https://boris.unibe.ch/id/eprint/152800

Actions (login required)

Edit item Edit item
Provide Feedback